- Home
- OIS vs IMMP Comparison
OIS vs IMMP Comparison
Compare OIS & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- IMMP
- Stock Information
- Founded
- OIS 1995
- IMMP 1987
- Country
- OIS United States
- IMMP Australia
- Employees
- OIS N/A
- IMMP N/A
- Industry
- OIS Metal Fabrications
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- OIS Industrials
- IMMP Health Care
- Exchange
- OIS Nasdaq
- IMMP Nasdaq
- Market Cap
- OIS 215.8M
- IMMP 211.1M
- IPO Year
- OIS 2001
- IMMP N/A
- Fundamental
- Price
- OIS $4.51
- IMMP $1.86
- Analyst Decision
- OIS Buy
- IMMP Buy
- Analyst Count
- OIS 3
- IMMP 2
- Target Price
- OIS $6.17
- IMMP $8.50
- AVG Volume (30 Days)
- OIS 910.7K
- IMMP 648.0K
- Earning Date
- OIS 05-01-2025
- IMMP 05-16-2025
- Dividend Yield
- OIS N/A
- IMMP N/A
- EPS Growth
- OIS N/A
- IMMP N/A
- EPS
- OIS 0.08
- IMMP N/A
- Revenue
- OIS $685,264,000.00
- IMMP $3,019,249.00
- Revenue This Year
- OIS $3.39
- IMMP $11.25
- Revenue Next Year
- OIS $6.66
- IMMP $10.22
- P/E Ratio
- OIS $56.44
- IMMP N/A
- Revenue Growth
- OIS N/A
- IMMP 24.11
- 52 Week Low
- OIS $3.08
- IMMP $1.32
- 52 Week High
- OIS $5.86
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- OIS 60.00
- IMMP 53.43
- Support Level
- OIS $4.10
- IMMP $1.44
- Resistance Level
- OIS $4.44
- IMMP $2.71
- Average True Range (ATR)
- OIS 0.24
- IMMP 0.17
- MACD
- OIS 0.15
- IMMP 0.05
- Stochastic Oscillator
- OIS 93.55
- IMMP 29.75
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.